Discover 1,506 paid clinical trials in Loveland, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,506
Pulmonary Health in Children With Down Syndrome
for
Down Syndrome, Dysphagia, Oropharyngeal
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 3 - 18
Code: NCT04398862
Recruiting
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
for
B-cell Acute Lymphoblastic Leukemia,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 0 - 30
Code: NCT04544592
Phase 1, Phase 2, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Aurora CO, Salt Lake City UT, Omaha NE, Lubbock TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Improving Immunization Rates in Transplant Candidates Through the Use of a Health Information Technology Tool
for
Transplantation Infection, Vaccination
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 17+
Code: NCT04336735
Recruiting
Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels
for
Hyperkalemia
Location: Aurora CO, Kansas City MO, Peoria IL, Nashville TN,
Sponsor: Vifor Pharma, Inc.
Sex: All
Age: 0 - 11
Code: NCT05766839
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 38
Code: NCT06131801
Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Aurora CO, Dallas TX, St Louis MO, San Bernardino CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations